Breaks Categories: News

MondayApr 23, 2018 9:29 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Initiates Human Clinical Study on TurboCBD Capsules; Presenting Breakthrough Nicotine Absorption Study Results

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has commenced a clinical study in Europe that is evaluating the cardiovascular and cognitive health effects of Lexaria's high absorption TurboCBD™ capsules. The data produced by the study will be of significant benefit to the company and its partners, providing objective human performance findings that will support the development of Lexaria’s next-generation cannabinoid product formulations. Results of the study are anticipated within 90 days. In addition, Lexaria also announced that it will be presenting the results of its recent breakthrough nicotine absorption study at…

Continue Reading

ThursdayApr 19, 2018 10:24 am

CannabisNewsBreaks – Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) and WeedMD, Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE) Enter Agreement to Merge

Canada’s first vertically-integrated cannabis brand house Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF), along with WeedMD Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE), this morning announced that the companies have entered into a definitive agreement to merge the two companies. Upon completion of the transaction, existing Hiku and WeedMD shareholders will own roughly 51.75% and 48.25% of the combined company, respectively, on a fully-diluted basis. Common shares of the resulting entity are anticipated to be listed on the TSX Venture Exchange, subject to regulatory approvals. Hiku and WeedMD are hosting a conference call on Friday, April 20, 2018 beginning at 10…

Continue Reading

ThursdayApr 19, 2018 9:42 am

CannabisNewsBreaks – Sunniva Inc. (SNNVF) Announces Plans to Release FY2017 Results on April 24

Vertically integrated medical cannabis company Sunniva Inc. (OTCQX: SNNVF) yesterday announced plans to release its fiscal results for the fourth quarter and year ended December 31, 2017, after market close on Tuesday, April 24, 2018. Per the update, the company’s executive management team will discuss the results during a conference call on Wednesday, April 25, 2018, at 11:30 am Eastern Time. Those interested in participating in this call can dial 1-800-319-4610 or 604-638-5340. An audio replay of the call will also be made available for two weeks following its conclusion. To access this replay, interested parties should dial 1-855-669-9658 or…

Continue Reading

ThursdayApr 19, 2018 9:10 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Inks Definitive Agreement to Acquire Island Green Cure Ltd.

British Columbia-based cannabis cultivation firm Choom Holdings (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has entered into a definitive agreement to acquire Island Green Cure Ltd. ("IGC"), an advanced-stage cannabis production license applicant under Health Canada's Access to Cannabis for Medical Purposes Regulations (“ACMPR”). IGC is currently in the "Confirmation of Readiness Stage" in the application process. Subject to customary closing conditions, the acquisition is anticipated to close at the end of April. "We are excited to secure our second acquisition and increase our total production capacity with another craft growing facility to cultivate Choom's premium handcrafted flower.…

Continue Reading

TuesdayApr 17, 2018 11:10 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Positive Topline Results from DehydraTECH™ Absorption Study

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced positive topline results following the completion of its first ingestible nicotine in vivo absorption study. The company is pursuing the use of its patented DehydraTECH™ technology as a new nicotine delivery method. The delivery method, in the form of an edible dose absorbed through the gastrointestinal tract, could potentially serve as a nicotine replacement therapy or as an alternative product format for regular tobacco users. Among other highlights, DehydraTECH™ demonstrated major nicotine absorption performance improvements including 1,160% faster delivery of equivalent peak quantities of nicotine to…

Continue Reading

TuesdayApr 17, 2018 10:33 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Secures Cannabis Retail Opportunities Throughout Western Canada

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has progressed the build-out of its cannabis retail store network. The company has applied to the Saskatchewan Liquor and Gaming Authority ("SLGA") for cannabis retail permits in 32 Zones across the province. The SLGA is expected to award the permits via lottery by June, 2018. In addition, Choom™ has secured nine retail locations with applications submitted in Alberta and has secured seven retail locations in British Columbia, all of which are subject to necessary governmental approvals being granted. "We have now established a…

Continue Reading

MondayApr 16, 2018 10:28 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Terminates LOI for the Acquisition of Agro-Biotech

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning reported that it has terminated the previously announced letter of intent (“LOI”) that it had entered into for the acquisition of Agro-Biotech. The company is currently reviewing its available legal alternatives to recover the amounts expended by the company in the pursuit of the transaction, as well as additional damages resulting from the non-completion of the transaction. "Despite our extensive efforts, we have been unable to complete the acquisition of Agro-Biotech in accordance with the terms and conditions initially agreed upon by the parties. While we…

Continue Reading

WednesdayApr 11, 2018 9:59 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces New Notice of Allowance from US Patent and Trademark Office

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has received another new Notice of Allowance from the United States Patent and Trademark Office providing claims that protect processes for making specific compositions of matter for enhanced cannabinoid delivery utilizing its DehydraTECH™ technology. This update comes on the heels of the company’s March 22, 2018, announcement of its reception of an additional Notice of Allowance for the compositions of matter. These two Notices of Allowance are expected to become Lexaria’s third and fourth granted patents in the United States. In recent months, Lexaria’s…

Continue Reading

MondayApr 09, 2018 1:00 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Schedules 2018 Annual Meeting; Announces Non-Brokered Private Placement

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced a non-brokered private placement of up to 16 million units at the price of $0.25 per unit for total gross proceeds of up to CAD$4,000,000. Each unit is comprised of one common share of the company and one warrant with an exercise price of $0.50 per share for a period of 24 months from the closing of the offering. The units are subject to an acceleration provision that enables sooner expiration of the warrants if the closing price of the shares on the Canadian Securities Exchange…

Continue Reading

MondayApr 09, 2018 12:01 pm

CannabisNewsBreaks – Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: CBWTF) Enters Agreement to Acquire Robinson’s Cannabis Inc.

Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: CBWTF) this morning announced that it has entered into a share purchase agreement with Robinson's Cannabis Inc. to acquire all of the issued and outstanding shares of Robinson's. Robinson's is a privately-owned licensed producer applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") that has completed Health Canada’s paper-based review process and is currently in the confirmation of readiness stage. Per the terms of the share purchase agreement, the company will acquire all of the issued and outstanding shares of Robinson's. Upon the completion of the acquisitions, which is subject to…

Continue Reading